# Protagonist Therapeutics, Inc: Form 8-K, filed May 30, 2023

- Company: [Protagonist Therapeutics, Inc](/companies/ptgx.md) (CIK 1377121)
- Form: 8-K
- Filed: 2023-05-30
- Accepted by EDGAR: May 30, 2023, 16:20 ET
- Period: 2023-05-25
- Accession: 0001104659-23-066057
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1377121/000110465923066057/tm2317329d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1377121/000110465923066057/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1377121/000110465923066057/tm2317329d1_8k.htm

Filed May 30, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-066057. Last ingested by Listed: Nov 6, 2026, 12:26 ET. No prices; not investment advice.